Last reviewed · How we verify

NCT04080349

Comparison of Vaginal Misoprostol and Dinoprostone Prior to Copper Intrauterine Device Insertion in Women Delivered Only by Cesarean Delivery

Status unknown Phase 4 Last updated 6 September 2019
What this trial tests

Phase 4 trial testing Dinoprostone 3 mg in IUD Pain in 300 participants. Status unknown.

Timeline
10 September 2019
Primary endpoint
30 November 2019
5 December 2019

Quick facts

Lead sponsorCairo University
PhasePhase 4
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposetreatment
Enrollment300
Start date10 September 2019
Primary completion30 November 2019
Estimated completion5 December 2019

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 18 to 45, female only, with IUD Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To compare the effect of vaginal dinoprostone versus vaginal misoprostol administered before the copper intrauterine device(IUD) insertion in reducing IUD insertion pain and the difficulty in inserting the IUD in women delivered only by cesarean section.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Dinoprostone 3 mg

Trials testing the same drug.

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04080349.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing